Status Topic selection
Technology type Medicine
Decision Not selected
Reason for decision Not eligible for Health Technology Evaluation guidance
Further information The NICE-Wide Prioritisation Board and NHS England have agreed that a Technology Appraisal (TA) would not be appropriate for this product and recommended that it is not selected for evaluation. Decision makers concluded that the clear rationale to not select is due to being a paediatric licence extension of the published adult TA853. NHS England will commission treatments for patients aged less than 18 years where specific commissioning conditions are met as per the Commissioning medicines for children in specialised services policy.
ID number 12109

Email enquiries


For further information on how we select topics for development, please see our page about topic selection